Zurcher Kantonalbank (Zurich Cantonalbank) Harmony Biosciences Holdings, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$39 Billion
Q2 2025

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 8,177 shares of HRMY stock, worth $217,181. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,177

Previous 8,177 -0.0%

Holding current value

$217,181

Previous $271,000 4.8%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$31.86 - $41.49 $96,472 - $125,631	3,028 Added 58.81%	8,177 $281,000
Q2 2024 Jul 29, 2024	SELL	$28.81 - $33.01 $62,258 - $71,334	-2,161 Reduced 29.56%	5,149 $155,000
Q1 2024 Apr 25, 2024	SELL	$29.93 - $35.06 $51,449 - $60,268	-1,719 Reduced 19.04%	7,310 $245,000
Q4 2023 Jan 30, 2024	BUY	$19.2 - $33.78 $23,673 - $41,650	1,233 Added 15.82%	9,029 $291,000
Q3 2023 Oct 25, 2023	BUY	$31.89 - $39.03 $97,583 - $119,431	3,060 Added 64.61%	7,796 $255,000
Q2 2023 Aug 07, 2023	BUY	$30.5 - $37.4 $41,998 - $51,499	1,377 Added 40.99%	4,736 $166,000
Q1 2023 May 08, 2023	SELL	$30.8 - $53.92 $2,895 - $5,068	-94 Reduced 2.72%	3,359 $109,000
Q4 2022 Feb 01, 2023	SELL	$45.4 - $60.91 $16,253 - $21,805	-358 Reduced 9.39%	3,453 $190,000
Q2 2022 Aug 09, 2022	SELL	$33.54 - $52.15 $41,790 - $64,978	-1,246 Reduced 24.64%	3,811 $186,000
Q1 2022 Apr 21, 2022	BUY	$33.14 - $51.13 $24,092 - $37,171	727 Added 16.79%	5,057 $246,000
Q4 2021 Feb 01, 2022	BUY	$34.09 - $43.91 $147,609 - $190,130	4,330 New	4,330 $185,000

Others Institutions Holding HRMY

# of Institutions

290

Shares Held

46.3M

Call Options Held

316K

Put Options Held

69.9K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $1.57B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Harmony Biosciences Holdings, Inc. Transaction History